MacroGenics, Inc. (MGNX) vs Veraxa Biotech AG (VRXA)

MacroGenics, Inc. MGNX 2.33 +4.95%
Veraxa Biotech AG VRXA 0.95 0.00%

MacroGenics, Inc. and Veraxa Biotech AG are both Biotechnology companies. MacroGenics, Inc. and Veraxa Biotech AG are of similar size ($148.4M and $140.4M).

Metric	MGNX	VRXA	Biotechnology median
P/E	n/m	—	10.60
P/S	0.88	—	9.40
P/B	3.46	—	2.13
Price to free cash flow	n/m	—	25.18
EV/EBITDA	0.61	—	0.66
EV/Sales	(0.11)	—	9.02
Earnings yield	(9.44%)	—	(32.88%)
Free cash flow yield	(44.23%)	—	(23.13%)

Metric	MGNX	VRXA	Biotechnology median
Gross margin	85.23%	—	68.51%
Operating margin	(20.45%)	—	0.00%
Net margin	(8.70%)	—	0.00%
Free cash flow margin	(39.08%)	—	0.00%
Return on equity	(32.61%)	—	(51.96%)
Return on assets	(4.94%)	—	(46.06%)
Return on invested capital	0.00%	—	0.00%

Metric	MGNX	VRXA	Biotechnology median
Revenue growth (TTM)	1.32%	—	6.76%
EPS growth (last fiscal year)	(10.28%)	—	29.88%
Revenue growth, 5-year CAGR	7.35%	—	9.75%
Net income growth, 5-year CAGR	0.00%	—	0.00%

Metric	MGNX	VRXA	Biotechnology median
Debt to equity	0.00	—	0.00
Current ratio	2.96	—	4.97
Net debt to EBITDA	2.82	—	1.01

Metric	MGNX	VRXA	Biotechnology median
Dividend yield	—	—	0.41%
Payout ratio	—	—	—

Metric	MGNX	VRXA	Biotechnology median
Market cap	148.42m	140.35m	161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack